Where Tech Meets Bio
Latest News
Nurix Therapeutics presented new data at the 2025 AACR Annual Meeting supporting the capabilities of its DEL-AI platform—a machine learning–powered system designed to accelerate discovery …
Read More
Eli Lilly Partners with Creyon Bio in $1B AI-Oligonucleotide Deal
Eli Lilly has signed a strategic partnership with Creyon Bio to develop AI-designed oligonucleotide therapeutics, committing $13 million upfront and up to $1 billion in performance-based …
Read More
NIH Launches Initiative to Prioritize Human-Based Research Technologies
The National Institutes of Health (NIH) has launched a new initiative to expand the use of human-based research technologies while reducing reliance on animal models, …
Read More
Latest News
Axiom Bio Launches with $15M to Replace Animal Testing with AI for Drug Toxicity Prediction
Raidium Publishes Promptable CT Foundation Model for Tumor Segmentation
Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation
NHS Wales Pilots Paige AI Tool to Triage Cancer Cases
Immunai and Parker Institute to Build Largest Single-Cell Dataset for Real-World Immunotherapy Research
Potato Lands $4.5M to Automate Lab Work with AI and Robots
Latest Insights
by Andrey Doronichev
AI Is Key to Democratizing Drug Discovery
The global drug development landscape is bustling, with over 20,000 biotechs competing for investor attention. Now more than ever, having a decisive edge is crucial …
Read More
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models to improve observational research, citing …
Read More
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
21 Life Science Marketplaces to Try in 2024
by Andrii Buvailo
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Partner Events

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Case Studies
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Interviews
[Interview] This Company Brings Quantum Tech Into Protein Design
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
[Interview] How D-Wave Brings Quantum Computing Into Biology
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Most Read
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
The Increasing Role of CROs in the Pharmaceutical Industry
13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)
11 Notable Companies Enabling Decentralized Clinical Trials